Loading...
Cogstate Limited
CGS.AX•ASX
Healthcare
Medical - Healthcare Information Services
A$1.66
A$-0.04(-2.35%)
Cogstate Limited (CGS.AX) Financial Performance & Statements
Review Cogstate Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
10.20%
↑ 10.20%
Operating Income Growth
80.98%
↑ 80.98%
Net Income Growth
2.75%
↑ 2.75%
Operating Cash Flow Growth
468.29%
↑ 468.29%
Operating Margin
26.52%
↑ 26.52%
Gross Margin
61.80%
↑ 61.80%
Net Profit Margin
14.85%
↑ 14.85%
ROE
20.39%
↑ 20.39%
ROIC
26.43%
↑ 26.43%
Cogstate Limited (CGS.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Cogstate Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $38.55M | $27.68M | $34.07M | $26.03M |
| Cost of Revenue | $14.34M | $24.08M | $22.49M | $25.37M |
| Gross Profit | $24.21M | $3.60M | $11.58M | $657396.00 |
| Gross Profit Ratio | $0.63 | $0.13 | $0.34 | $0.03 |
| R&D Expenses | $10.42M | $1.47M | $9.47M | $1.17M |
| SG&A Expenses | $4.14M | $4.41M | $4.75M | $4.12M |
| Operating Expenses | $22.26M | $4.41M | $4.75M | $4.12M |
| Total Costs & Expenses | $28.37M | $28.48M | $27.24M | $29.49M |
| Interest Income | $0.00 | $0.00 | $660683.00 | $382676.00 |
| Interest Expense | $26370.00 | $51901.00 | $44320.00 | $59489.00 |
| Depreciation & Amortization | $244184.00 | $2.19M | $1.96M | $1.90M |
| EBITDA | $7.12M | $5.45M | $6.48M | $1.96M |
| EBITDA Ratio | $0.18 | $0.05 | $0.26 | -$0.06 |
| Operating Income | $10.18M | -$808260.00 | $6.83M | -$3.46M |
| Operating Income Ratio | $0.26 | -$0.03 | $0.20 | -$0.13 |
| Other Income/Expenses (Net) | -$2.67M | $540586.00 | -$2.35M | $3.46M |
| Income Before Tax | $7.51M | $3.21M | $4.48M | $605.00 |
| Income Before Tax Ratio | $0.19 | $0.12 | $0.13 | $0.00 |
| Income Tax Expense | $2.35M | $130992.00 | -$713735.00 | -$90258.00 |
| Net Income | $5.16M | $3.07M | $5.19M | $90862.00 |
| Net Income Ratio | $0.13 | $0.11 | $0.15 | $0.003 |
| EPS | $0.03 | $0.02 | $0.03 | $0.001 |
| Diluted EPS | $0.03 | $0.02 | $0.03 | $0.00 |
| Weighted Avg Shares Outstanding | $171.66M | $171.37M | $173.44M | $173.46M |
| Weighted Avg Shares Outstanding (Diluted) | $172.35M | $174.41M | $175.95M | $202.87M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan